Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hereditary Breast/Ovarian Cancer (brca1, brca2)”

29 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 29 results

Not applicableStudy completedNCT02133703
What this trial is testing

Decision Support Following Genetic Testing for Breast-Ovarian Cancer Susceptibility

Who this might be right for
Breast CancerOvarian Cancer
Georgetown University 369
Large-scale testing (Phase 3)Study completedNCT00685256
What this trial is testing

Standard Genetic Counseling With or Without a Decision Guide in Improving Communication Between Mothers Undergoing BRCA1/2 Testing and Their Minor-Age Children

Who this might be right for
Breast CancerHereditary Breast/Ovarian Cancer (brca1, brca2)
Georgetown University 245
Not applicableUnknownNCT00855998
What this trial is testing

Thymidine Kinase 1 in Risk Assessment for Hereditary Breast /Ovarian Cancer

Who this might be right for
Breast CancerOvarian Cancer
Hadassah Medical Organization 300
Not applicableStudy completedNCT03510689
What this trial is testing

Genetics and Heart Health After Cancer Therapy

Who this might be right for
Breast CancerHereditary Breast/Ovarian Cancer (brca1, Brca2)Heart Diseases+1 more
Abramson Cancer Center at Penn Medicine 79
Not applicableStudy completedNCT03225170
What this trial is testing

Is it Feasible?: Self-Affirmation for Hereditary Breast and Ovarian Cancer Genetic Counseling

Who this might be right for
Breast Cancer
National Human Genome Research Institute (NHGRI) 64
Testing effectiveness (Phase 2)Study completedNCT00253539
What this trial is testing

Arzoxifene or Tamoxifen in Preventing Breast Cancer in Premenopausal Women at High Risk for Breast Cancer

Who this might be right for
Breast CancerHereditary Breast/Ovarian Cancer (brca1, brca2)
The Cleveland Clinic 3
Not applicableActive Not RecruitingNCT04261972
What this trial is testing

Cell-free DNA in Hereditary And High-Risk Malignancies 1

Who this might be right for
Hereditary Cancer Syndrome
University Health Network, Toronto 1,416
Not applicableActive Not RecruitingNCT01608074
What this trial is testing

Radical Fimbriectomy for Young BRCA Mutation Carriers

Who this might be right for
BRCA1 MutationBRCA2 MutationHereditary Breast and Ovarian Cancer
Centre Oscar Lambret 123
Not applicableNot Yet RecruitingNCT07236359
What this trial is testing

Evaluation of Well Being and Patient Reported Outcomes After Robotic Single-port Nipple Sparing Mastectomy and Implant Reconstruction

Who this might be right for
Breast ReconstructionBreast CancerHereditary Breast/Ovarian Cancer (brca1, brca2)+1 more
Beaumont Hospital 108
Not applicableEnded earlyNCT01374685
What this trial is testing

Family Communication of Hereditary Breast and Ovarian Cancer Risk Among African Americans

Who this might be right for
Ovarian NeoplasmCancer GeneticsBreast Cancer
National Human Genome Research Institute (NHGRI) 8
Not applicableUnknownNCT01273909
What this trial is testing

Outcomes After Perforator Flap Reconstruction for Breast Reconstruction and/or Lymphedema Treatment

Who this might be right for
Breast CancerHereditary Breast/Ovarian Cancer (brca1, brca2)Acquired Lymphedema+1 more
The National Institute of Lymphology 1,000
Not applicableActive Not RecruitingNCT02194387
What this trial is testing

Energy Balance Interventions in Increasing Physical Activity in Breast Cancer Gene Positive Patients, Lynch Syndrome-Positive Patients, CLL Survivors or High-Risk Family Members

Who this might be right for
Body Mass Index 25 or GreaterBRCA1 Gene MutationBRCA2 Gene Mutation+8 more
M.D. Anderson Cancer Center 337
Not applicableStudy completedNCT00001468
What this trial is testing

Outcomes of Education and Counseling for BRCA1 Testing

Who this might be right for
Breast NeoplasmsOvarian Neoplasms
National Human Genome Research Institute (NHGRI) 1,500
Not applicableStudy completedNCT02451735
What this trial is testing

Genetic Counseling for Breast Cancer Survivors (GC for BC)

Who this might be right for
Breast Cancer
H. Lee Moffitt Cancer Center and Research Institute 157
Early research (Phase 1)Study completedNCT00535119
What this trial is testing

Veliparib, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Cancer

Who this might be right for
Adult Solid NeoplasmBRCA1 Mutation CarrierBRCA2 Mutation Carrier+1 more
National Cancer Institute (NCI) 107
Not applicableLooking for participantsNCT00005095
What this trial is testing

Specimen and Data Study for Ovarian Cancer Early Detection and Prevention

Who this might be right for
Cervical CancerEndometrial CancerFallopian Tube Cancer+6 more
Northwestern University 6,000
Not applicableLooking for participantsNCT07039552
What this trial is testing

Development and Validation of an Ovarian Cancer Risk Prediction Model for Family Members of Ovarian Cancer Probands

Who this might be right for
Hereditary Breast and Ovarian Cancer SyndromeBRCA Mutations
Peking University Third Hospital 10,000
Not applicableActive Not RecruitingNCT01230346
What this trial is testing

Culturally-Informed Counseling in Latinas at High Risk for Hereditary Breast or Ovarian Cancer

Who this might be right for
No Evidence of DiseaseBRCA1 SyndromeBRCA2 Syndrome+2 more
City of Hope Medical Center 493
Not applicableEnrolling By InvitationNCT06914726
What this trial is testing

Patient Centered Clinical Decision Support for Hereditary Cancer Syndromes

Who this might be right for
Hereditary Breast/Ovarian Cancer (brca1, brca2)Lynch SyndromeGenetic Variation+2 more
HealthPartners Institute 2,488
Large-scale testing (Phase 3)Study completedNCT00673335
What this trial is testing

Letrozole in Preventing Breast Cancer in Postmenopausal Women With a BRCA1 or BRCA2 Mutation

Who this might be right for
brca1 Mutation Carrierbrca2 Mutation CarrierBreast Cancer+1 more
UNICANCER 170
Load More Results